Search company, investor...
Deutsche Arzt company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series A | Alive

About Deutsche Arzt

Deutsche Arzt is a provider of digital solutions health solutions, aiming to connect doctors, patients, physiotherapists, and health insurance funds via its online platform. DAAG's service portfolio includes, among other things, supply contracts with large health insurance companies to provide online therapy and online (video) consultations.

Deutsche Arzt Headquarters Location

Im Teelbruch 122

Essen, D-45219,


+49 02054 93856-0

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Deutsche Arzt

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Deutsche Arzt is included in 3 Expert Collections, including Health Plans & Benefits Management.


Health Plans & Benefits Management

724 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.


Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,853 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Latest Deutsche Arzt News

ARQIS advises Quadriga Capital on investment in United Therapy - ARQIS

Mar 22, 2022

ARQIS advises Quadriga Capital on investment in United Therapy ARQIS advises Quadriga Capital on investment in United Therapy Share: 10. March 2022 ARQIS has advised Quadriga Capital Fonds (“Quadriga Capital”) as shareholders of the emerging physiotherapy group UNITED THERAPY. With the merger of UNITED THERAPY, which arises from NOVOTERGUM GmbH and Deutsche Arzt AG, a new provider in the German physiotherapy market is being formed with the support of Quadriga Capital. It will combine analog physiotherapy with digital telemedicine services. The goal of the physiotherapy group is to be an innovative ecosystem and network for holistic care solutions. Quadriga Capital, Luxempart S.A., Deutsche Arzt AG and NOVO-T AG signed the merger agreement at the end of February. The transaction is expected to close in the first quarter of 2022. Jochen Roeser, spokesman for the management board of NOVOTERGUM GmbH, will become the future CEO of UNITED THERAPY, which can already count on more than 600 employees at the start and is planning further growth. NOVO-T AG brings its subsidiary NOVOTERGUM GmbH, one of the leading physiotherapy chains with over 50 locations in Germany, into the merger. Deutsche Arzt AG contributes its innovative digital appbased solutions for therapy management and prevention, as well as its health insurance direct contracts and national orthopedic care network. As part of the transaction, Deutsche Arzt AG is transferring its business operations to Deutsche Arzt Management GmbH, a subsidiary of UNITED THERAPY. The Luxembourg-based, listed investment company Luxempart S.A. is leaving the group of shareholders after three years of successful support. Quadriga Capital is an experienced partner in the transformation of healthcare companies. The healthcare, tech-enabled services and smart industries sectors are the focus of Quadriga Capital’s longterm and sustainable investments. The ARQIS team led by Jörn-Christian Schulze has many years of successful experience supporting financial investors, particularly in the healthcare and nursing sector. The team was most recently active for Quadriga Capital in the acquisition and expansion of the care platform wecare. Advisors to Quadriga Capital ARQIS: Dr. Jörn-Christian Schulze (Lead), Johannes Landry, Dr. Ulrich Lienhard, Marcus Nothhelfer, Dr. Hendrik von Mellenthin; Counsel: Sina Janke, Jens Knipping, Saskia Kirschbaum, Anja Markworth; Associates: Kamil Flak (Lead Due Diligence), Severin Steffens, Dr. Nima Hanifi-Atashgah, Nora Meyer-Stratmann, Martin Weingärtner, Dr. Martina Berenbrinker, Tim Bresemann, Christos Choudeloudis, Laura Rizzi, Daniel Schlemann, Jasmin Stuckenbrock, Rolf Tichy, Nathalie Wintermeier; Legal Specialists: Carina Grahs, Gloria Bittner-Schützendorf, Maria Fischer, Hannah Potter, Julia Regenauer, Qing Xia HOW CAN WE HELP YOU? If you have any questions, please write to us.

  • Where is Deutsche Arzt's headquarters?

    Deutsche Arzt's headquarters is located at Im Teelbruch 122, Essen.

  • What is Deutsche Arzt's latest funding round?

    Deutsche Arzt's latest funding round is Series A.

  • Who are the investors of Deutsche Arzt?

    Investors of Deutsche Arzt include Novinvest, NRW.Bank and Abrechnungs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.